Intellectual Property India Publishes Patent Application for 'Multispecific Molecules For Clearance Of Immunoglobulins In The Treatment Of Autoantibody-Induced Diseases' Filed by Amgen Inc.

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517046093 A) filed by Amgen Inc., Thousand Oaks, U.S.A., on May 13, for 'multispecific molecules for clearance of immunoglobulins in the treatment of autoantibody-induced diseases.'

Inventor(s) include Devanaboyina, Venkata Siva Charan; and Li, Peng.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "The present invention is directed to multispecific molecules that bind immunoglobulin and a recycling target. Binding immunoglobulin and a recycling target results in degradation of immunoglobulin and in certain embodiments recycling of the multispeci...